Bharat Immunologicals Market Capitalization vs. Revenue

BIBCL -- India Stock  

INR 20.40  1.55  8.22%

The Drivers Module shows relationships between Bharat Immunologicals's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of Bharat Immunologicals Biologicals Corp Ltd over time as well as its relative position and ranking within its peers. Check also Trending Equities

Bharat Immunologicals Revenue vs. Market Capitalization Fundamental Analysis

Bharat Immunologicals Biologicals Corp Ltd is rated below average in market capitalization category among related companies. It is rated below average in revenue category among related companies totaling about  0.77  of Revenue per Market Capitalization. The ratio of Market Capitalization to Revenue for Bharat Immunologicals Biologicals Corp Ltd is roughly  1.30 
Market Capitalization is total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Bharat Immunologicals 
Market Cap 
 = 
Shares Outstanding 
X  
Share Price 
=
969.39 M
In most publications or references market cap is broken down into the mega cap, large cap, mid cap, small cap, micro cap, and nano cap. Market Cap is a measurement of business as total market value of all of outstanding shares at a given time, and can be used to compare different companies based on their size.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of business and is important item when evaluating financial statements of a company. Revenues from a firm's main business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which given company operates.
Bharat Immunologicals 
Revenue 
 = 
Money Received 
Discounts and Returns 
=
744.6 M
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can includes product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.